Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:GNSNYSE:MED On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGNSGenius Group$0.36-14.0%$0.30$0.21▼$5.69$2.68M10.452.87 million shs2.44 million shsMEDMedifast$12.78+0.5%$13.22$11.57▼$26.85$140.47M0.96300,402 shs218,448 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGNSGenius Group+1.56%+28.35%+56.30%-11.16%-89.30%MEDMedifast-2.97%-2.15%+0.52%-15.42%-49.72%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGNSGenius Group0.7866 of 5 stars0.02.00.00.02.01.71.3MEDMedifast3.9012 of 5 stars3.02.00.02.02.21.72.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGNSGenius Group 0.00N/AN/AN/AMEDMedifast 2.00Hold$16.5029.11% UpsideCurrent Analyst Ratings BreakdownLatest CSRT, IDH, MED, and GNS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/19/2025MEDMedifastDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$17.00 ➝ $16.50(Data available from 5/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGNSGenius Group$23.06M0.12N/AN/A$2.67 per share0.14MEDMedifast$543.45M0.26$2.62 per share4.88$19.21 per share0.67Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGNSGenius Group-$5.66MN/A0.00N/AN/AN/AN/AN/A5/21/2025 (Estimated)MEDMedifast$99.42M-$0.6571.008.35N/A0.35%10.64%7.57%N/ALatest CSRT, IDH, MED, and GNS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/21/2025H2 2024GNSGenius Group-$0.05N/AN/AN/A$12.85 millionN/A4/28/2025Q1 2025MEDMedifast-$0.07-$0.11-$0.04-$0.07$114.85 million$115.73 million2/18/2025Q4 2024MEDMedifast-$0.16$0.10+$0.26$0.08$114.25 million$119.00 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGNSGenius GroupN/AN/AN/AN/AN/AMEDMedifast$6.6051.64%N/AN/A N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGNSGenius Group0.022.522.48MEDMedifastN/A3.342.55Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGNSGenius Group14.28%MEDMedifast95.51%Insider OwnershipCompanyInsider OwnershipGNSGenius Group51.19%MEDMedifast2.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGNSGenius Group4807.39 million3.61 millionNot OptionableMEDMedifast87010.99 million10.67 millionOptionableCSRT, IDH, MED, and GNS HeadlinesRecent News About These CompaniesMED Q1 Earnings Call: Revenue Misses, Coach Productivity and GLP-1 Strategy in FocusMay 12 at 5:33 PM | finance.yahoo.comIs Medifast’s Revenue Decline Changing Its Earnings Per Share Trajectory?May 2, 2025 | kalkinemedia.comEarnings Release: Here's Why Analysts Cut Their Medifast, Inc. (NYSE:MED) Price Target To US$15.00May 2, 2025 | finance.yahoo.comMedifast First Quarter 2025 Earnings: EPS Beats ExpectationsMay 1, 2025 | finance.yahoo.comMedifast (NYSE:MED) Releases Q2 2025 Earnings GuidanceApril 30, 2025 | marketbeat.comMedifast (NYSE:MED) Posts Quarterly Earnings Results, Beats Expectations By $0.09 EPSApril 30, 2025 | marketbeat.comMedifast’s Earnings Call: Mixed Sentiment Amid ChallengesApril 29, 2025 | tipranks.comMedifast, Inc. (NYSE:MED) Q1 2025 Earnings Call TranscriptApril 29, 2025 | msn.comMedifast Q1 Loss Wider Than Expected, Sales Down 33.8% Y/YApril 29, 2025 | zacks.comQ1 2025 Medifast Inc Earnings CallApril 29, 2025 | finance.yahoo.comMarshall Wace LLP Takes $1.84 Million Position in Medifast, Inc. (NYSE:MED)April 29, 2025 | marketbeat.comMedifast Q1 2025 slides: Adapting strategy for GLP-1 era amid revenue challengesApril 29, 2025 | investing.comMedifast shares drop as revenue misses estimates, guidance disappointsApril 29, 2025 | investing.comMedifast Announces First Quarter 2025 Financial ResultsApril 29, 2025 | finance.yahoo.comMedifast Inc (MED) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic FocusApril 29, 2025 | uk.finance.yahoo.comMedifast projects Q2 2025 revenue of $85M-$105M amid coach strategy enhancementsApril 29, 2025 | msn.comMedifast (NYSE:MED) Misses Q1 Sales TargetsApril 29, 2025 | msn.comQ1 2025 Medifast Inc Earnings Call TranscriptApril 29, 2025 | gurufocus.comU.S. Meal Replacements Market Faces $1.5 Billion Setback Due to GLP-1 Drugs - U.S. Meal Replacements Market Report 2025April 28, 2025 | finance.yahoo.comEarnings To Watch: Medifast (MED) Reports Q1 Results TomorrowApril 27, 2025 | msn.comJPMorgan Chase & Co. Increases Stock Position in Medifast, Inc. (NYSE:MED)April 27, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Mid-Cap Medical Stocks Outperforming the MarketBy Ryan Hasson | May 6, 2025View 3 Mid-Cap Medical Stocks Outperforming the Market3 Boring Stocks Outperforming the Market This YearBy Ryan Hasson | April 25, 2025View 3 Boring Stocks Outperforming the Market This YearMedtronic: A Dividend Aristocrat With Stability and InnovationBy Jeffrey Neal Johnson | April 22, 2025View Medtronic: A Dividend Aristocrat With Stability and InnovationJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? By Chris Markoch | April 16, 2025View Johnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Financial Sector: Pullback Opportunity or Warning Sign?By Ryan Hasson | April 15, 2025View Financial Sector: Pullback Opportunity or Warning Sign?CSRT, IDH, MED, and GNS Company DescriptionsGenius Group NYSEAMERICAN:GNS$0.36 -0.06 (-13.98%) As of 04:10 PM EasternGenius Group Limited, through its subsidiaries, provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company operates through two segments, Education and Campus. It develops comprehensive entrepreneurial education curriculum with a full suite of tools for student learning and faculty earning. The company also owns entrepreneur resorts in Bali and South Africa, which run entrepreneur retreats and workshops; and Genius Café, an entrepreneur beach club in Bali, as well as Genius Central, an entrepreneur co-working hub in Singapore. In addition, it offers home childcare and investment education services; operates entrepreneur education campus that provides a range of programs from pre-primary through primary school, secondary school, and vocational college; and provides career-focused on-campus and online programs at the master's, bachelor's and associate degree level, as well as certificate and continuing education programs. The company operates in Europe/the Middle East/Africa, the Asia/Pacific, and North America/South America. Genius Group Limited was founded in 2002 and is headquartered in Singapore.Medifast NYSE:MED$12.78 +0.06 (+0.47%) As of 03:46 PM EasternMedifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start AMD’s AI-Powered Stock Price Rally Just Shifted Gears Oklo Reaches Critical Mass, Atomic Upside Still Available Is Verizon a Buy? Q1 Results and Solid Dividend Make Bullish Case Carnival's Comeback: Is the Stock Set for a Profitable Journey? 5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears U.S. Regulators Target CrowdStrike: Is It a Signal or Noise? Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
